Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
KP Tissue ( (TSE:KPT) ) has provided an announcement.
KP Tissue Inc. reported record revenue exceeding $2 billion for 2024, with strong Adjusted EBITDA across all quarters, despite challenges like volatile pulp prices. The company is exploring the construction of a new manufacturing facility to enhance its market share and product offerings in North America. Additionally, KP Tissue is preparing contingency plans to address potential U.S. tariffs and is leveraging patriotic consumer sentiment in Canada through marketing campaigns.
More about KP Tissue
KP Tissue Inc. is a leading Canadian manufacturer of quality tissue products, serving both the consumer market with brands like Cashmere, Purex, and Scotties, and the Away-From-Home market. The company is expanding its presence in the U.S. consumer tissue business with the White Cloud brand and premium private label products.
YTD Price Performance: -1.84%
Average Trading Volume: 15,054
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$80.05M
See more data about KPT stock on TipRanks’ Stock Analysis page.